These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 29397524

  • 1. Rationale and design of the TRICHAMPION trial: Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy Patients.
    Berruezo A, Linhart M, Auricchio A, Zamorano JL, Santamaria P, Borràs R, Burgos F, Brugada J.
    J Interv Card Electrophysiol; 2018 Mar; 51(2):117-124. PubMed ID: 29397524
    [Abstract] [Full Text] [Related]

  • 2. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
    Lucon A, Palud L, Pavin D, Donal E, Behar N, Leclercq C, Mabo P, Daubert JC.
    Arch Cardiovasc Dis; 2013 Mar; 106(6-7):373-81. PubMed ID: 23806305
    [Abstract] [Full Text] [Related]

  • 3. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D.
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Symptomatic hypertrophic obstructive cardiomyopathy: the role of dual-chamber pacing.
    Park MH, Gilligan DM, Bernardo NL, Topaz O.
    Angiology; 1999 Feb; 50(2):87-94. PubMed ID: 10063938
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study.
    Nishimura RA, Hayes DL, Ilstrup DM, Holmes DR, Tajik AJ.
    J Am Coll Cardiol; 1996 Feb; 27(2):421-30. PubMed ID: 8557915
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).
    Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS.
    Circulation; 1999 Jun 08; 99(22):2927-33. PubMed ID: 10359738
    [Abstract] [Full Text] [Related]

  • 13. Dual chamber pacing for patients with hypertrophic obstructive cardiomyopathy: a clinical perspective in 2000.
    Erwin JP, Nishimura RA, Lloyd MA, Tajik AJ.
    Mayo Clin Proc; 2000 Feb 08; 75(2):173-80. PubMed ID: 10683657
    [Abstract] [Full Text] [Related]

  • 14. Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy.
    Rishi F, Hulse JE, Auld DO, McRae G, Kaltman J, Kanter K, Williams W, Campbell RM.
    J Am Coll Cardiol; 1997 Mar 15; 29(4):734-40. PubMed ID: 9091517
    [Abstract] [Full Text] [Related]

  • 15. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy].
    Gao YC, Li Y, Han ZH, Zhang XL, Zhao H, Jiang TY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr 15; 35(4):333-6. PubMed ID: 17711659
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.